About Us
StemCode was founded in 2020 when Swiss researchers developed Augmented NAC — a breakthrough formulation using a proprietary enhancement process that achieved 99% spike protein denaturation rates, now available as Zero Spike.
Karen Mutasa, founder of the Mweya Group, owns StemCode and established it as the exclusive distributor for Zero Spike with Augmented NAC for Africa and the Middle East, bringing this innovation to underserved markets.
Our Values
Scientific Rigor
Every claim backed by laboratory data and clinical research.
Regional Expertise
Understanding unique healthcare landscapes across MEA markets.
Partnerships
Building long-term relationships with clinics and wellness centers.
The Mweya Group
The Mweya Group owns StemCode and specializes in distributing Zero Spike with Augmented NAC across Africa and the Middle East.
Mweya (Shona for "soul" or "spirit") reflects our philosophy of excellence infused with authenticity and purpose. We bring world-class cellular health solutions to markets that need them most.
